BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Viralytics Ltd 

66 Hunter Street, Suite 305, Level 3

  Sydney  2000  Australia
Phone: 61-2-8889-3671 Fax: 61-2-8068-6038


SEARCH JOBS


Industry
Biotechnology






 Company News
Viralytics Ltd (VLA.AX) Release: Positive Interim Phase 2 Trial Results For CAVATAK™, Novel Cancer Immunotherapy 4/8/2014 4:20:05 PM    More...
Viralytics Ltd (VLA.AX) Completes $27 Million Fund Raising 3/13/2014 8:59:47 AM    More...
Viralytics Ltd (VLA.AX) To Present At Two US Institutional Investor Forums 3/7/2014 6:34:43 AM    More...
Viralytics Ltd (VLA.AX) Seeks $27 Million To Fund Cancer Trials 1/30/2014 6:43:23 AM    More...
Viralytics Ltd (VLA.AX) Release: Target Enrollment Achieved In CAVATAK™ USA Phase 2 Melanoma Trial With Excellent Interim Results 1/8/2014 10:12:23 AM    More...
Viralytics Ltd (VLA.AX) Meets Primary Endpoint in CAVATAK Phase 2 Melanoma Trial 9/18/2013 6:35:48 AM    More...
Viralytics Ltd Full Year Financial Results 9/3/2013 6:32:28 AM    More...
Viralytics Ltd to Present at 15th Annual Rodman & Renshaw Global Investment Conference 8/27/2013 6:19:48 AM    More...
Viralytics Ltd Advances CAVATAK™ Clinical Programs in Late Stage Melanoma, Prostate, Breast and Colorectal Cancers 7/29/2013 9:28:21 AM    More...
Starpharma Holdings Ltd VP Dr Malcolm McColl Appointed CEO of Viralytics Ltd 11/14/2012 7:27:15 AM    More...
12

//-->